Profusa amends convertible note deal: four tranches totaling $22.2M; conversion price reset with floor

Profusa, Inc.

Restructured SPA into four tranches: $10M (closed July 11), $2.22M, $5.56M, $4.44M; aggregate $22.2M principal.
Conversion price now lower of original or 95% of lowest 10-day VWAP; floor set at 20% of Aug 22 closing price.
Additional closings contingent on S-1 effectiveness, no Nasdaq deficiency, stockholder approval (proxy due Sept 5, 2025).
Notes priced at 90% of face value ($20M total purchase price for $22.22M principal); company released claims.
SPA amendment includes stockholder approval requirement; company must file definitive proxy by September 5, 2025.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.